Lakefront Biotherapeutics NV (LKFT)

LKFT Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,092	1,166	316.42	287	277.38	280.46
Revenue Growth	234.71%	268.41%	10.25%	3.47%	-1.10%	-47.11%
Gross Profit Gross Profit Growth	1,071	1,136	281.56	287	277.38	280.46
Operating Income Operating Income Growth	390.04	295.04	-188.34	-88.26	-131.06	-171.57
Net Income Net Income Growth	488.78	320.88	74.08	211.7	-217.99	-103.23
Earnings Per Share EPS Growth	7.42	4.87	1.12	3.21	-3.32	-1.58
EPS Growth	-	334.82%	-65.11%	-	-	-

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States of America United States of America Growth	1,081	240.79	239.71	241.15	234.34
Europe Europe Growth	31.1	34.86	0.02	0.1	0.04
Total Total Growth	1,112	275.65	239.72	241.25	234.38

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	2,982	2,998	3,118	3,685	4,094	4,703
Total Debt Total Debt Growth	6.44	6.92	11.72	9.6	21.9	26.86
Net Cash (Debt) Net Cash Growth	2,976	2,991	3,106	3,675	4,072	4,676
Net Cash Growth	-9.45%	-3.69%	-15.48%	-9.75%	-12.92%	-8.88%
Net Cash Per Share Net Cash Per Share Growth	45.17	45.39	47.13	55.78	61.98	71.39

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-301.6	-257.46	-320.03	-405.97	-500.54	-503.83
Capital Expenditures CapEx Growth	-8.73	-13.7	-16.72	-18.71	-27.39	-54.21
Free Cash Flow Free Cash Flow Growth	-310.33	-271.16	-336.75	-424.68	-527.93	-558.03
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	98.09%	97.45%	88.98%	100.00%	100.00%	100.00%
Operating Margin	35.73%	25.31%	-59.52%	-30.75%	-47.25%	-61.17%
Pretax Margin	43.16%	25.81%	-0.97%	1.96%	-25.54%	-42.57%
Profit Margin	41.63%	24.21%	-1.54%	5.31%	-25.34%	-42.08%
FCF Margin	-28.43%	-23.26%	-106.42%	-147.97%	-190.33%	-198.97%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	3.21	5.72	23.60	11.46	-	-
PS Ratio	1.50	1.58	5.50	8.44	9.82	11.33

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: May 6, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error